Most relevant biologically was that in this model of infection, in vivo injection of antibody to CD95L, which blocks the interaction with CD95, reduced apoptosis, improved type-1 immune responses, and reduced the infection severity as estimated by parasitemia [37]. This evidence concerns the gene FAS and infection.